4//SEC Filing
Pearce Samantha 4
Accession 0001784606-24-000012
CIK 0001232524other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:33 PM ET
Size
6.6 KB
Accession
0001784606-24-000012
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2024-01-17+2,210→ 15,369 total - Tax Payment
Ordinary Shares
2024-01-17$119.13/sh−1,038$123,657→ 14,331 total
Footnotes (2)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.
- [F2]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001805688
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:33 PM ET
- Size
- 6.6 KB